AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Weitman, S Barrera, H Moore, R Gonzalez, C Marty, J Hilsenbeck, S MacDonald, JR Waters, SJ Von Hoff, D
Citation: S. Weitman et al., MGI 114: Augmentation of antitumor activity when combined with topotecan, J PED H ONC, 22(4), 2000, pp. 306-314

Authors: Prepiorka, D Blamble, D Hilsenbeck, S Danielson, M Krance, R Chan, KW
Citation: D. Prepiorka et al., Tacrolimus clearance is age-dependent within the pediatric population, BONE MAR TR, 26(6), 2000, pp. 601-605

Authors: Fuqua, SAW Wiltschke, C Zhang, QX Borg, A Castles, CG Friedrichs, WE Hopp, T Hilsenbeck, S Mohsin, S O'Connell, P Allred, DC
Citation: Saw. Fuqua et al., A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions, CANCER RES, 60(15), 2000, pp. 4026-4029

Authors: O'Connell, P Fischbach, K Hilsenbeck, S Mohsin, SK Fuqua, SAW Clark, GM Osborne, CK Allred, DC
Citation: P. O'Connell et al., Loss of heterozygosity at D14S62 and metastatic potential of breast cancer, J NAT CANC, 91(16), 1999, pp. 1391-1397

Authors: Lichtenstein, MJ Marshall, C Pruski, L Blalock, C Lee, S Murphy, D Hilsenbeck, S
Citation: Mj. Lichtenstein et al., Positively aging (TM): Choices and changes creating interdisciplinary middle school teaching materials using examples from geriatrics and gerontology, EDUC GERON, 25(6), 1999, pp. 555-569

Authors: Britten, CD Izbicka, E Hilsenbeck, S Lawrence, R Davidson, K Cerna, C Gomez, L Rowinsky, EK Weitman, S Von Hoff, DD
Citation: Cd. Britten et al., Activity of the multitargeted antifolate LY231514 in the human tumor cloning assay, CANC CHEMOT, 44(2), 1999, pp. 105-110

Authors: Weitman, S Mangold, G Marty, J Dexter, D Hilsenbeck, S Rake, J Juniewicz, P Von Hoff, D
Citation: S. Weitman et al., Evidence of enhanced in vivo activity using tirapazamine with paclitaxel and paraplatin regimens against the MV-522 human lung cancer xenograft, CANC CHEMOT, 43(5), 1999, pp. 402-408
Risultati: 1-7 |